CytomX Therapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4/ACytomX Therapeutics, Inc.CTMX2d

   CTMX CEO McCarthy sells shares

   • 101,793 shares sold at $4.54
   • 101,793 shares purchased at $1.59
   • 1,089,684 shares held after transactions

   Sean A. McCarthy, reporting

2. ROUTINESCHEDULE 13G/ACytomX Therapeutics, Inc.CTMXAug 14

   Ownership stake disclosure by Point72 Asset Management, L.P. (amended)

   Point72 Asset Management, L.P., filed by

3. ROUTINESCHEDULE 13G/ACytomX Therapeutics, Inc.CTMXAug 14

   Ownership stake disclosure by Kynam Capital Management, LP (amended)

   Kynam Capital Management, LP, filed by

4. ROUTINESCHEDULE 13GCytomX Therapeutics, Inc.CTMXAug 7

   Ownership stake disclosure by STATE STREET CORP

   STATE STREET CORP, filed by

5. ROUTINES-8CytomX Therapeutics, Inc.CTMXAug 6

   Employee stock plan registration

6. ROUTINE8-KCytomX Therapeutics, Inc.CTMXAug 6

   Current report

7. NOTABLE10-QCytomX Therapeutics, Inc.CTMXAug 6

   Quarterly report

8. ROUTINE4CytomX Therapeutics, Inc.CTMXAug 5

   2 insider filings

   Alejandra Carvajal, insider filing for CTMX

   Show all 2

   • 4Insider filing for CTMXAug 5
   • 3New insider at CTMXAug 5

   Alejandra Carvajal, reporting

9. ROUTINESCHEDULE 13GCytomX Therapeutics, Inc.CTMXAug 3

   Ownership stake disclosure by BANK OF AMERICA CORP /DE/

   BANK OF AMERICA CORP /DE/, filed by

10. ROUTINE4CytomX Therapeutics, Inc.CTMXJul 30

    2 insider filings

    Charles S. Fuchs, insider filing for CTMX

    Show all 2

    • 4Insider filing for CTMXJul 30
    • 3New insider at CTMXJul 30

    Charles S. Fuchs, reporting

11. ROUTINESCHEDULE 13GCytomX Therapeutics, Inc.CTMXJul 27

    Ownership stake disclosure by BlackRock, Inc.

    BlackRock, Inc., filed by

12. ROUTINE8-KCytomX Therapeutics, Inc.CTMXJul 27

    Current report

13. ROUTINE4CytomX Therapeutics, Inc.CTMXJun 22

    7 insider filings

    Zhen Su, insider filing for CTMX

    Show all 7

    • 4Insider filing for CTMXJun 22
    • 4Insider filing for CTMXJun 22
    • 4Insider filing for CTMXJun 22
    • 4Insider filing for CTMXJun 22
    • 4Insider filing for CTMXJun 22
    • 4Insider filing for CTMXJun 22
    • 4Insider filing for CTMXJun 22

    Zhen Su, reporting

14. ROUTINE8-KCytomX Therapeutics, Inc.CTMXJun 22

    Current report

15. ROUTINE4CytomX Therapeutics, Inc.CTMXJun 17

    Christopher Ogden, insider filing for CTMX

    Christopher Ogden, reporting

16. ROUTINE8-KCytomX Therapeutics, Inc.CTMXJun 3

    Current report

17. ROUTINESCHEDULE 13G/ACytomX Therapeutics, Inc.CTMXMay 15

    5 13G filings

    Ownership stake disclosure by Seven Fleet Capital Management LP (amended)

    Show all 5

    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15
    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15
    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15
    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15
    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15

    Seven Fleet Capital Management LP, filed by

18. ROUTINE8-KCytomX Therapeutics, Inc.CTMXMay 7

    Current report

19. NOTABLE10-QCytomX Therapeutics, Inc.CTMXMay 7

    Quarterly report

20. ROUTINEDEFA14ACytomX Therapeutics, Inc.CTMXApr 30

    Additional proxy materials

21. ROUTINEDEF 14ACytomX Therapeutics, Inc.CTMXApr 30

    Proxy statement

22. ROUTINEPRE 14ACytomX Therapeutics, Inc.CTMXApr 20

    Preliminary proxy statement

23. ROUTINESCHEDULE 13GCytomX Therapeutics, Inc.CTMXApr 16

    Ownership stake disclosure by Point72 Asset Management, L.P.

    Point72 Asset Management, L.P., filed by

24. ROUTINESCHEDULE 13G/ACytomX Therapeutics, Inc.CTMXMar 26

    Ownership stake disclosure by VANGUARD GROUP INC (amended)

    VANGUARD GROUP INC, filed by

25. ROUTINE4CytomX Therapeutics, Inc.CTMXMar 19

    4 insider filings

    Yu-Waye Chu, insider filing for CTMX

    Show all 4

    • 4Insider filing for CTMXMar 19
    • 4Insider filing for CTMXMar 19
    • 4Insider filing for CTMXMar 19
    • 4Insider filing for CTMXMar 19

    Yu-Waye Chu, reporting

26. ROUTINE8-KCytomX Therapeutics, Inc.CTMXMar 19

    Current report

27. ROUTINE424B5CytomX Therapeutics, Inc.CTMXMar 18

    Securities offering

28. ROUTINE424B5CytomX Therapeutics, Inc.CTMXMar 16

    Securities offering

29. ROUTINES-3ASRCytomX Therapeutics, Inc.CTMXMar 16

    Securities offering

30. ROUTINE8-KCytomX Therapeutics, Inc.CTMXMar 16

    Current report

31. NOTABLE10-KCytomX Therapeutics, Inc.CTMXMar 16

    Annual report

32. ROUTINESCHEDULE 13GCytomX Therapeutics, Inc.CTMXMar 4

    Ownership stake disclosure by Kynam Capital Management, LP

    Kynam Capital Management, LP, filed by

33. ROUTINESCHEDULE 13G/ACytomX Therapeutics, Inc.CTMXFeb 17

    Ownership stake disclosure by ORBIMED ADVISORS LLC (amended)

    ORBIMED ADVISORS LLC, filed by

34. ROUTINESCHEDULE 13G/ACytomX Therapeutics, Inc.CTMXFeb 17

    Ownership stake disclosure by TANG CAPITAL MANAGEMENT LLC (amended)

    TANG CAPITAL MANAGEMENT LLC, filed by

35. ROUTINESCHEDULE 13G/ACytomX Therapeutics, Inc.CTMXFeb 5

    Ownership stake disclosure by FMR LLC (amended)

    FMR LLC, filed by

Older filings on EDGAR